Unique conformational dynamics and protein recognition of A-to-I hyper-edited dsRNA
- PMID: 40568935
- PMCID: PMC12199146
- DOI: 10.1093/nar/gkaf550
Unique conformational dynamics and protein recognition of A-to-I hyper-edited dsRNA
Abstract
Adenosine-to-inosine (A-to-I) editing is a highly abundant modification of double-stranded RNA (dsRNA) and plays an important role in posttranscriptional gene regulation. Editing of multiple inosines by the ADAR1 enzyme leads to A-to-I hyper-editing of non-coding dsRNA, such as 3'UTRs, transposable elements, or foreign pathogenic RNAs, and is implicated in immune response and human diseases including cancer. The structural consequences of hyper-editing and its role in protein binding are poorly understood. Here, we combine solution nuclear magnetic resonance spectroscopy (NMR), biophysical methods such as small-angle X-ray scattering, and molecular dynamics simulations to study the sequence-dependent effects on conformation and dynamics of A-to-I hyper-editing for a 20-mer dsRNA and recognition of such RNAs by Endonuclease V. By comparing non-edited, single-edited, and hyper-edited dsRNA, we identify unique conformational features and extensive dynamics associated with hyper-editing, resulting in significantly increased base-pair opening. Hyper-edited dsRNA is more extended and adopts a highly dynamic ensemble of canonical and non-canonical conformations, which lead to preferential binding by Endonuclease V. Our integrated experimental and computational analysis identifies unique structural and dynamic features that are likely linked to specific protein recognition and the unique biological consequences of hyper-editing.
© The Author(s) 2025. Published by Oxford University Press on behalf of Nucleic Acids Research.
Conflict of interest statement
None declared.
Figures







Similar articles
-
Inflammation primes the murine kidney for recovery by activating AZIN1 adenosine-to-inosine editing.J Clin Invest. 2024 Sep 3;134(17):e180117. doi: 10.1172/JCI180117. J Clin Invest. 2024. PMID: 38954486 Free PMC article.
-
A novel mechanism for A-to-I RNA-edited CYP1A1 in promoting cancer progression in NSCLC.Cell Mol Biol Lett. 2025 Apr 2;30(1):40. doi: 10.1186/s11658-025-00718-6. Cell Mol Biol Lett. 2025. PMID: 40175891 Free PMC article.
-
Systematic analysis of A-to-I RNA editing upon release of ADAR from the nucleolus.RNA Biol. 2025 Dec;22(1):1-18. doi: 10.1080/15476286.2025.2515655. Epub 2025 Jun 24. RNA Biol. 2025. PMID: 40464638
-
Adenosine-to-inosine RNA editing in cancer: molecular mechanisms and downstream targets.Protein Cell. 2025 Jun 20;16(6):391-417. doi: 10.1093/procel/pwae039. Protein Cell. 2025. PMID: 39126156 Free PMC article. Review.
-
ADAR1-mediated RNA editing in breast cancer: molecular mechanisms and therapeutic implications.Med Oncol. 2025 Aug 9;42(9):421. doi: 10.1007/s12032-025-02979-9. Med Oncol. 2025. PMID: 40782195 Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous